"It is with great pleasure that I announce the nomination of Mr. Jean-François Côté as CFO of Aplantex. Jean-François is a seasoned finance professional with over 20 years of experience in business, financial management, and strategic business development. As a co-founder of Kasto Finance, he is dedicated to turning the financial challenges of startups and mid-market companies into strategic opportunities by offering tailored financing solutions and advanced expertise in financial structuring. His skills and acumen will help us further fuel our growth momentum," underlines Mr. Patrick Charest, B. Sc., P.Eng., Aplantex CEO.
Before founding Kasto Finance, Jean-François held leadership positions in financial management, where he demonstrated his ability to optimize financial performance and support business growth. His solid experience in financial analysis, modeling, and strategic planning enables him to provide insightful advice and build trusted relationships with investors and financial partners.
Jean-François holds a degree in management accounting and continues to enhance his skills through various training programs and certifications. He is also active in the business community, regularly participating in conferences and workshops to share his expertise and network with other industry professionals.
Patricia Houle leaves a sound heritage
"As the outgoing initial CFO, Mrs. Patricia Houle, CMA, CPA, MBA, passes the baton after steering Aplantex through the extremely demanding stages we faced as a biotech start-up. We are most grateful for her exceptional contribution to our sound financial footing. Thanks to her skills and commitment, we are ready for our next leap forward," states Mr. Charest.
The successful transition from start-up to full operation
With our nursery and genetics, growth, and extraction labs now in operation, 2025 will see Aplantex complete the work under several LOIs with leading international buyers of plant-based molecules. Mr. Côté will prepare the next round of financing slated for the first half of 2026.
About Aplantex
Aplantex's scientific team has developed a unique process for the local production of high value-added active plant ingredients, highly prized by major players in many sectors. The heart of this green biotechnology process is the continuous production, in a controlled environment, of plant biomass from proprietary photosynthetic plant replicators. This abundant biomass is then dried, and the extraction, fractionation and purification stages enable us to isolate the specific molecules essential to many of the leading products in the cosmetics, natural health, agrifood, and pharmaceutical industries.
For more information on Aplantex, visit: https://aplantex.ca
View source version on businesswire.com: https://www.businesswire.com/news/home/20250203644966/en/
Contacts
Marc-André Ménard, CMO
mamenard@aplantex.ca
450 531-2275
